Swiss National Bank held its stake in shares of AngioDynamics Inc. (NASDAQ:ANGO) during the second quarter, Holdings Channel reports. The institutional investor owned 48,900 shares of the company’s stock at the end of the second quarter. Swiss National Bank owned about 0.13% of AngioDynamics worth $703,000 as of its most recent filing with the SEC.
A number of other large investors have also recently modified their holdings of ANGO. BNP Paribas Arbitrage SA boosted its stake in shares of AngioDynamics by 99.2% in the second quarter. BNP Paribas Arbitrage SA now owns 8,174 shares of the company’s stock valued at $117,000 after buying an additional 4,071 shares during the last quarter. Bank of Montreal Can bought a new stake in AngioDynamics during the second quarter valued at approximately $201,000. Jacobs Levy Equity Management Inc. bought a new stake in AngioDynamics during the first quarter valued at approximately $289,000. Strs Ohio increased its stake in AngioDynamics by 76.0% in the second quarter. Strs Ohio now owns 22,700 shares of the company’s stock valued at $326,000 after buying an additional 9,800 shares during the period. Finally, Kennedy Capital Management Inc. bought a new stake in AngioDynamics during the first quarter valued at approximately $589,000. 69.29% of the stock is currently owned by institutional investors.
AngioDynamics Inc. (NASDAQ:ANGO) traded down 1.56% during midday trading on Tuesday, reaching $17.01. The company’s stock had a trading volume of 89,972 shares. AngioDynamics Inc. has a 12-month low of $9.71 and a 12-month high of $17.64. The firm has a 50 day moving average price of $16.85 and a 200-day moving average price of $14.40. The company’s market cap is $624.93 million.
AngioDynamics (NASDAQ:ANGO) last issued its quarterly earnings results on Wednesday, October 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.13 by $0.04. AngioDynamics had a positive return on equity of 4.46% and a negative net margin of 11.84%. The firm earned $88.10 million during the quarter. During the same period in the prior year, the business posted $0.11 earnings per share. AngioDynamics’s revenue was up 5.3% on a year-over-year basis. On average, equities research analysts predict that AngioDynamics Inc. will post $0.66 earnings per share for the current fiscal year.
ANGO has been the topic of several analyst reports. KeyCorp set a $18.00 target price on AngioDynamics and gave the stock a “buy” rating in a report on Monday, September 12th. Zacks Investment Research raised AngioDynamics from a “sell” rating to a “hold” rating in a report on Monday, July 25th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $15.25.
In related news, major shareholder Avista Capital Partners Gp, Ll sold 2,241,000 shares of the firm’s stock in a transaction that occurred on Friday, August 5th. The stock was sold at an average price of $14.62, for a total transaction of $32,763,420.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director David F. Burgstahler sold 2,250,000 shares of the firm’s stock in a transaction that occurred on Friday, August 5th. The stock was sold at an average price of $14.62, for a total value of $32,895,000.00. Following the sale, the director now directly owns 23,988 shares of the company’s stock, valued at $350,704.56. The disclosure for this sale can be found here. Corporate insiders own 1.88% of the company’s stock.
AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease, and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.
Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics Inc. (NASDAQ:ANGO).
Receive News & Ratings for AngioDynamics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.